Analysis of Serum Creatinine Levels, Blood Pressure and Grade of Hypertension of Chronic Disease Management Program Participants
DOI:
https://doi.org/10.31964/mltj.v10i2.619Keywords:
Creatinine levels, correlation, hypertensionAbstract
Indonesia is one of the countries with the highest number of cases of hypertension in the world; the predominant patient is the elderly. In some patients with hypertension, increased blood pressure causes impaired salt and creatinine excretion, resulting in poor kidney function. A chronic disease management program is a health care system with a proactive-integrative approach to prevent further complications. The research objective is to analyze serum creatinine levels, blood pressure, and hypertension grade and determine the relationship between serum creatinine and blood pressure in chronic disease management program participants. The study subjects, 73 participants with hypertension, were obtained by purposive sampling. Patient data and hypertension grade were obtained from medical records; an auto chemistry analyzer analyzed serum creatinine. Data were analyzed using the Pearson correlation test using SPSS. Participants with hypertension fall into the elderly age (60-69 years), totalling 31 (42%); pre-elderly age (45–59 years) includes 28 (38%); and high-risk elderly age (>70 years) includes 14 (19%). Most of the participants (40 participants) fell into hypertension stage II, followed by hypertension stage I (25 participants), and only 8 participants fell into the elevated category. The mean serum creatinine of participants with Elevated blood pressure criteria was 0.89±0.178, Hypertension grade I 0.91±0.322, and hypertension grade II 0.99±0.269, illustrating a trend of increasing serum creatinine levels due to higher blood pressure criteria. Pearson correlation test shows a significant correlation between both systolic blood pressure with serum creatinine levels (p<0.05, r=0.2) and diastolic blood pressure with serum creatinine levels (p=0.007, r=0.342). There was a trend of increasing serum creatinine levels corresponding to the hypertension grade in participants. Blood pressure was significantly correlated with serum creatinine, clearly confirming that an increase in blood pressure may followed by an increase in serum creatinine.References
Ameer, O. Z. (2022). Hypertension in chronic kidney disease: What lies behind the scene. Frontiers in Pharmacology, 13(October), 1–28. https://doi.org/10.3389/ fphar.2022.949260
Angeli, F., Gentile, G., Trapasso, M., Verdecchia, P., & Reboldi, G. (2018). Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease. Journal of Human Hypertension, 32(8), 625–632. https://doi.org/10.1038/s41371-018-0081-y
Azwaldi, A., Maksuk, M., Putri Maharani, & Intan Kumalasari. (2023). Determınant factors of hypertensıon ın the elderly at publıc health center ın Palembang, south Sumatera Indonesıa. Epidemiological Journal of Indonesia, 2(1 SE-Article), 1–6. https://journal.paei.or.id/eji/article/view/9
Barreto, E. F., Rule, A. D., Murad, M. H., Kashani, K. B., Lieske, J. C., Erwin, P. J., Steckelberg, J. M., Gajic, O., Reid, J. M., & Kane-Gill, S. L. (2019). Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review. Mayo Clinic Proceedings, 94(3), 500–514. https://doi.org/10.1016/j. mayocp.2018.08.002
Bozkurt, B., Aguilar, D., Deswal, A., Dunbar, S. B., Francis, G. S., Horwich, T., Jessup, M., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., Rosendorff, C., & Yancy, C. (2016). Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association. Circulation, 134(23), e535–e578. https://doi.org/10.1161/CIR.0000000000000 450
Chang, A. R., & Appel, L. J. (2018). Target Blood Pressure for Cardiovascular Disease Prevention in Patients with CKD. Clinical Journal of the American Society of Nephrology : CJASN, 13(10), 1572–1574. https://doi.org/10.2215/CJN.02130218
Duni, A., Dounousi, E., Pavlakou, P., Eleftheriadis, T., & Liakopoulos, V. (2019). Hypertension in Chronic Kidney Disease: Novel Insights. Current Hypertension Reviews, 16(1), 45–54. https://doi.org/10.2174/1573402115666190415153554
Garfinkle, M. A. (2017). Salt and essential hypertension: pathophysiology and implications for treatment. Journal of the American Society of Hypertension, 11(6), 385–391. https://doi.org/10.1016/j.jash.2017.04.006
Ghufron Mukti, A. (2021). Optimalisasi dan pengelolaan penyakit kronis selama pandemi covid-19. BPJS Kesehatan, 3.
Haad, C. R., Pelegrín, C. M., López, A. I. R., & Olmo, R. S. (2023). Hypertension and the kidneys. Medicine (Spain), 13(83), 4875–4882. https://doi.org/10.1016/j.med. 2023.06.017
Harrison, D. G., Coffman, T. M., & Wilcox, C. S. (2021). Pathophysiology of Hypertension: The Mosaic Theory and Beyond. Circulation Research, 128(7), 847–863. https://doi.org/10.1161/CIRCRESAHA.121.318082
Huan, Y., Cohen, D. L., & Townsend, R. R. (2015). Pathophysiology of Hypertension in Chronic Kidney Disease. In Chronic Renal Disease (pp. 163–169). Elsevier Inc. https://doi.org/10.1016/B978-0-12-411602-3.00014-7
Kashani, K., Rosner, M. H., & Ostermann, M. (2020). Creatinine: From physiology to clinical application. European Journal of Internal Medicine, 72(July), 9–14. https://doi.org/10.1016/j.ejim.2019.10.025
Kemenkes RI. (2018). Laporan Nasional Riskesdas 2018. In Lembaga Penerbit Balitbangkes.https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan Riskesdas 2018 Nasional.pdf
Luft, F. C. (2021). Biomarkers and predicting acute kidney injury. Acta Physiologica, 231(1), 1–12. https://doi.org/10.1111/apha.13479
Meiriana, A., Trisnantoro, L., & Padmawati, R. S. (2019). Implementasi Program Pengelolaan Penyakit Kronis (Prolanis) Pada Penyakit Hipertensi di Puskesmas Jetis Kota Yogyakarta. Jurnal Kebijakan Kesehatan Indonesia : Jkki Volume, 08(02), 51–58.
Meti, K. ., & Nurjanah, L. S. . (2018). Gambaran Kadar Kreatinin Darah Pada Penderita Hipertensi Lebih Dari 2 Tahun. Prosiding Seminar Nasional Dan Diseminasi Penelitian Kesehatan STIKes Bakti Tunas Husada Tasikmalaya , 3(5), 160–162. http://www.academia.edu/5932965/Hipertensi_dan_Kreatinin
Nappoe, S. A., Djasri, H., & Kurniawan, M. F. (2023). Chronic disease management programme (PROLANIS) in Indonesia: Case study. In Iris.Who.Int. https://iris.who.int/bitstream/handle/10665/373226/9789240079052-eng.pdf?sequence=1
Nuswantoro, A., Aprillia, D., Purwaningsih, I., & Arifa, R. (2022). Profile Of Renal Function Laboratory Examinations In Prolanis Patients In Pontianak City Ari. Jurnal Laboratorium Khatulistiwa, 8(1), 65–68.
Pugh, D., Gallacher, P. J., & Dhaun, N. (2019). Management of Hypertension in Chronic Kidney Disease. Drugs, 79(4), 365–379. https://doi.org/10.1007/s40265-019-1064-1
Purwati N, I., & Indrawati, U. (2017). Pengaruh program pengelolaan penyakıt kronıs (Prolanıs) terhadap penurunan tekanan darah pada pasıen hıpertensı berbasıs teorı carıng. Jurnal Insan Cendekia, 6(1), 1–8.
Qolbi, H. H., Fitriyani, A. W., Wijayanti, S., Fajarulhuda, M., & Maulana, A. R. (2023). 45. Blood Pressure Description in PROLANIS Community in Bandung, West Java. Journal of Hypertension, 41(Suppl 2). https: //journals.lww.com/ jhypertension/fulltext/2023/04002/45__blood_pressure_description_in_prolanis.45.aspx
Rahayu, C., & Indriyani, A. S. (2021). Gambaran Kadar Kreatinin Pada Penderita Hipertensi Di Rumah Sakit Dr.Abdul Radjak Salemba. Anakes : Jurnal Ilmiah Analis Kesehatan, 7(2), 204–216. https://doi.org/10.37012/anakes.v7i2.684
Roche Diagnostics. (2019). Cobas Integra ® 400 plus (Version 3.6) User Manual Version 3.2. file:///D:/school vista/leerjaar 4/stage/examens/CRP/theorie/User manual versie 3.2.pdf
Samartkit, P., & Pullteap, S. (2024). Non-invasive continuous blood pressure sensors in biomedical engineering research: A review. Sensors and Actuators A: Physical, 367, 115084. https://doi.org/10.1016/j.sna.2024.115084
Sulastomo, H., Fauzi, F. A., & Kusumawati, R. (2018). Left Ventricular Hypertrophy dan Fungsi Ginjal pada Penderita Hipertensi. Smart Medical Journal, 1(2).
Vinet, L., & Zhedanov, A. (2011). A “missing” family of classical orthogonal polynomials. Journal of Physics A: Mathematical and Theoretical. https://doi.org/10.1088/1751-8113/44/8/085201
Yusransyah, Halimah, E., & Suwantika, A. A. (2020). Measurement of the Quality of Life of Prolanis Hypertension Patients in Sixteen Primary Healthcare Centers in Pandeglang District, Banten Province, Indonesia, Using EQ-5D-5L Instrument. Patient Preference and Adherence, 14, 1103–1109. https://doi.org/10.2147/PPA.S249085
Yuziani, Y., & Sofia, R. (2023). Correlation between chronic disease management program (prolanis) activities and health status of hypertension patients at Muara Satu community health center, Lhokseumawe city. Jurnal Kedokteran Syiah Kuala, 23(2), 261–268. https://doi.org/10.24815/jks.v23i2.31600
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Asbar Tanjung, Ika Nurhidayah, Sharfina Maulidayanti, Ing Mayfa Br Situmorang

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.